Find clinical trials for Acute Myeloid Leukemia (AML) in Indianapolis, IN
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Acute Myeloid Leukemia (AML) trials near Indianapolis, IN, USA:
\[GO\]) improves survival of children/adolescents/young adults with acute myeloid leukemia (AML) in 1st relapse w...
Phase 3
Indianapolis, Indiana, United States and 85 other locations
Eligible untreated patients with FLT3 acute myeloid leukemia (AML) between the ages of 18 and 70 will be randomiz...
Phase 2
Indianapolis, Indiana, United States and 43 other locations
will be evaluated in patients with relapsed or refractory (R/R) acute myeloid leukemia (AML). The main study has ...
Phase 1, Phase 2
Indianapolis, Indiana, United States and 55 other locations
in combination with venetoclax for the treatment of newly diagnosed acute myeloid leukemia (AML) in adults who ar...
Phase 1, Phase 2
Indianapolis, Indiana, United States and 33 other locations
engineered T-cells (CD4CAR) in patients with relapsed or refractory AML. The study will evaluate safety in this patient population and also ...
Phase 1
Indianapolis, Indiana, United States and 3 other locations
with fludarabine and cytarabine in treating patients with acute myeloid leukemia (AML), myelodysplastic syndrome ...
Phase 1
Indianapolis, Indiana, United States and 17 other locations
survival (OS), and disease progression, including progression to acute myeloid leukemia (AML) in transfusion-depe...
Phase 2, Phase 3
Indianapolis, Indiana, United States and 126 other locations
Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage
Phase III, multicenter, randomized study with two arms (1:1 ratio) enrolling patients with AML relapsed/refractory after 2, 3, or 4 prior in...
Phase 3
Indianapolis, Indiana, United States and 38 other locations
chemotherapy and bone marrow transplantation in newly diagnosed AML subjects with FLT3 mutation. About 510 subjects will be randomized in a ...
Phase 3
Indianapolis, Indiana, United States and 30 other locations
Clinical trials
Research sites
Resources
Legal